FSSNX
Price
$27.92
Change
-$1.28 (-4.38%)
Updated
Dec 18 closing price
IJSAX
Price
$14.32
Change
-$0.61 (-4.09%)
Updated
Dec 18 closing price
Ad is loading...

FSSNX vs IJSAX

Header iconFSSNX vs IJSAX Comparison
Open Charts FSSNX vs IJSAXBanner chart's image
Fidelity Small Cap Index
Price$27.92
Change-$1.28 (-4.38%)
VolumeN/A
CapitalizationN/A
VY® JPMorgan Small Cap Core Equity A
Price$14.32
Change-$0.61 (-4.09%)
VolumeN/A
CapitalizationN/A
FSSNX vs IJSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. IJSAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and IJSAX is a Hold.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 29.5B vs. IJSAX (445M). FSSNX pays higher dividends than IJSAX: FSSNX (1.36) vs IJSAX (0.00). FSSNX was incepted earlier than IJSAX: FSSNX (13 years) vs IJSAX (20 years). FSSNX (0) and IJSAX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 19.49 vs. IJSAX (17.34). FSSNX return over 5 years is better than : 46.38 vs. IJSAX (0.59).
FSSNXIJSAXFSSNX / IJSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years20 years-
Gain YTD16.77015.167111%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets29.5B445M6,629%
Annual Yield % from dividends1.360.00-
Returns for 1 year19.4917.34112%
Returns for 3 years12.65-19.39-65%
Returns for 5 years46.380.597,907%
Returns for 10 years90.42-23.61-383%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AENT6.250.42
+7.20%
Alliance Entertainment Holding Corp
IDYA26.330.28
+1.07%
IDEAYA Biosciences
BIO337.85-5.10
-1.49%
Bio-Rad Laboratories IncClass A
BFST27.02-0.76
-2.74%
Business First Bancshares
PCSA1.01-0.03
-2.88%
Processa Pharmaceuticals